🇺🇸 Tablet Pyridoxine hydrochloride in United States

11 US adverse-event reports

Safety signals — FAERS

Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.

• Window: 22 April 2025 – 22 April 2026
• Total reports: 11

Most-reported reactions

1. Asthenia — 2 reports (18.18%)
2. Arthritis — 1 report (9.09%)
3. Blood Urine Present — 1 report (9.09%)
4. Diarrhoea — 1 report (9.09%)
5. Eye Pain — 1 report (9.09%)
6. Fatigue — 1 report (9.09%)
7. Gait Disturbance — 1 report (9.09%)
8. Haemoglobin Decreased — 1 report (9.09%)
9. Kidney Infection — 1 report (9.09%)
10. Mallory-Weiss Syndrome — 1 report (9.09%)

Source database →

Frequently asked questions

Is Tablet Pyridoxine hydrochloride approved in United States?

Tablet Pyridoxine hydrochloride does not currently have US marketing authorisation in our dataset.

Who is the marketing authorisation holder for Tablet Pyridoxine hydrochloride in United States?

Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh is the originator. The local marketing authorisation holder may differ — check the official source linked above.